Squarepoint Ops »

Lineage Cell Therapeutics In shares owned by Squarepoint Ops

Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Squarepoint Ops from 13F filings

Historical chart of Squarepoint Ops investment in Lineage Cell Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including Lineage Cell Therapeutics In held by Squarepoint Ops consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lineage Cell Therapeutics In by Squarepoint Ops

Quarter filed Position value Share count Share price at filing
2023-12-31 $189k 173k 1.09
2023-09-30 $29k 25k 1.18
2023-06-30 $45k 32k 1.41
2023-03-31 $49k 33k 1.50

More positions owned by Squarepoint Ops

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Apple (AAPL)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Microsoft Corporation Call Option (MSFT)
Ishares Tr Msci Eafe Etf Put Option (EFA)
Tesla Motors Put Option (TSLA)
NVIDIA Corporation Put Option (NVDA)
Pdd Holdings Sponsored Ads (PDD)
Amazon Call Option (AMZN)
Meta Platforms Cl A (META)
Ishares Tr Msci Emg Mkt Etf Put Option (EEM)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Advanced Micro Devices Call Option (AMD)
Royal Caribbean Cruises (RCL)
Alphabet Cap Stk Cl A Call Option (GOOGL)

View all positions for Squarepoint Ops

Top funds holding Lineage Cell Therapeutics In

BlackRock
Vanguard Group
Defender Capital
Raffles Associates
Prescott General Partners
MAI Wealth Advisors
Jpmorgan Chase & Co
Citadel Advisors
Laurion Capital Management
Charles Schwab Investment Management
Bank of New York Mellon
Long Focus Capital Management
Connor, Clark & Lunn Investment Management
Barclays
Royal Bank of Canada

View all funds holding Lineage Cell Therapeutics In